Stockreport

Progenics shares jump 21% premarket after FDA says it will review treatment for rare cancer [MarketWatch]

PROGENICS PHARMACEUTICALS  (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
PDF Progenics shares jump 21% premarket after FDA says it will review treatment for rare cancer Shares of Progenics Pharmaceuticals Inc. PGNX, +14.53% surged 21% in prema [Read more]